What changed from existing technology?
This study developed an AI system that uses CT scans to estimate blood vessel density in lung cancer, which could help doctors assess the cancer's growth without surgery.
This is the first AI system to use CT scans for noninvasive assessment of microvessel density in lung adenocarcinoma, which could improve preoperative cancer evaluation.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 0
- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This AI system could potentially aid in noninvasive preoperative assessment of lung adenocarcinoma by estimating microvessel density from CT scans.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.